However, ongoing research, such as the FLOW trial, which had been comparing GLP-1RAs to a placebo in patients with T2D and CKD, was recently halted prematurely due to their effectiveness
Every one of those scenarios carries a real risk of serious harm, Rozalina McCoy, MD, vice chief of clinical research in the Division of Endocrinology, Diabetes, and Nutrition, at the University of Maryland School of Medicine, told Verywell Health
Learn more about the cost for Vitamin C IVs
Genetic Predisposition Some people have a genetic predisposition to kidney problems, including infections
Im starting to sense that doctors thresholds to stop GLP-1s are driven by the desire for fewer inbox messages than what would be best for the patientthings like trying a different version of a drug, or changing the usual dosing regimen
Some patients report that tirzepatide produces less nausea than semaglutide at equivalent efficacy levels, though everyones experience is different